Moreover, the overexpression of CD55 inhibits complement activation; this could be of interest in Alzheimer’s disease (AD) since the deposition of complement is observed in the brains of patients with AD [51]. This evidence concerns the gene CD55 and early-onset autosomal dominant Alzheimer disease.